You are viewing a limited version of this profile. To access i3's full capabilities.
Microvi Biotechnologies
Save
Company logo (jpg or png)
Parent company

Short description

Developer of biotechnologies for the water, wastewater and renewable chemical industries

Founded in 2008
Founded in

Company type Private Public ()
Company type

Industry Group

Sector

TRL Range 9
TRL 1 Basic research
TRL 2 Technology formulation
TRL 3 Applied research
TRL 4 Small scale prototype
TRL 5 Large scale prototype
TRL 6 Prototype system
TRL 7 Demonstration system
TRL 8 First of a kind commercial system
TRL 9 Full commercial application
TRL Range

Ticker

Headquarters Hayward, CA Hayward, United States
Address
City
State
Zip
Country

Parent Companies

Updated by at on 01/14/2025

Traction
  • 0 M&A items
tags
Similar companies
Customers
Save
Date Company
12/01/2018

Scottish Water Scottish Water

Confirmed by Scottish Water

Partnerships
Save
Date Partner Type
02/17/2021
Nexilico Nexilico
In collaboration with Nexilico, Inc. Microvi will apply machine learning and bioinformatics to develop a new generation of biological treatment processes. The project seeks to drive breakthrough improvements in the removal of complex pollutants in water at unprecedented rates and effectiveness.
View source    
Confirmed by Nexilico
Joint Venture
Investment Rounds
Save

IPO INFORMATION

Date

IPO status

IPO Type

Amount

Initial shares

Ticker symbol

Exchange listed

Prospectus URL

Prospectus

Source URL

Source

Description

Date Investors Type Amount
10/15/2022 National Institute of Health National Institute of Health (1)
Post-money valuation of
Funds will be used to scale up its technology to eliminate chromium, a chemical found in drinking water.
Grant $1,100,000
Click to add IPO information
Products
Save
Product image Name Product status Revenue model Cost metrics

Microvi MicroNiche Engineering (MNE) Platform

Microvi’s MicroNiche Engineering™ Technology Platorm lies at the intersection of biology and materials science, using a combinatorial approach to synthesize biocatalysts optimized for various bioprocesses.

Wide Commercial Availability
$/kW (current)
$/kW (projected)
$/kWh (current)
$/kWh (projected)
You are viewing a limited version of this profile. To access i3's full capabilities.
Back to top

Preload svg text font